Safety Warning: DAC Version Inferior to Exogenous GH for Flat GH Elevation Goals
The speaker issues an implicit safety and efficacy warning against using CJC-1295 with DAC, arguing that if a user's goal is sustained, flat GH elevation, exogenous growth hormone is a superior and better-studied option with decades of clinical data. Using DAC CJC-1295 for this purpose is presented as an inferior choice that undermines the rationale for using a secretagogue in the first place.
CJC-1295 Without DAC Recommended Over DAC Version
The speaker explicitly recommends CJC-1295 without DAC as the only version worth purchasing for those seeking to preserve the natural pulsatile GH release pattern. The DAC version is compared unfavorably to exogenous growth hormone, which the speaker notes has decades of clinical data behind it for producing flat GH elevation. No-DAC CJC-1295 is preferred for maintaining physiological GH pulsatility.
CJC-1295 with DAC Eliminates Natural Pulsatile GH Release Pattern
CJC-1295 with DAC binds to proteins in the blood, extending its half-life to approximately 7 days, allowing once or twice weekly injections. However, this extended half-life produces a flat, continuous baseline of growth hormone releasing hormone rather than the sharp, pulsatile release the pituitary is designed to respond to. The speaker argues this defeats the primary purpose of using a secretagogue over exogenous growth hormone.